Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Fulgent Genetics Inc.

    NASDAQ: FLGT · Real-Time Price · USD
    20.27
    -0.67 (-3.20%)
    At close: Jun 17, 2025, 3:59 PM
    20.50
    1.13%
    After-hours: Jun 17, 2025, 05:00 PM EDT

    Fulgent Genetics Statistics

    Share Statistics

    Fulgent Genetics has 30.44M shares outstanding. The number of shares has increased by 3.15% in one year.

    Shares Outstanding

    n/a
    		 30.44M

    Shares Change (YoY)

    n/a
    		 3.15%

    Shares Change (QoQ)

    n/a
    		 0.91%

    Owned by Institutions (%)

    n/a
    		 56.02%

    Shares Floating

    n/a
    		 19.61M

    Failed to Deliver (FTD) Shares

    n/a
    		 260

    FTD / Avg. Volume

    n/a
    		 0.06%

    Short Selling Information

    The latest short interest is 1.61M, so 5.21% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.61M

    Short % of Shares Out

    n/a
    		 5.21%

    Short % of Float

    n/a
    		 9.48%

    Short Ratio (days to cover)

    n/a
    		 5.46

    Valuation Ratios

    The PE ratio is -13.08 and the forward PE ratio is -33.21. Fulgent Genetics's PEG ratio is 0.17.

    PE Ratio

    n/a
    		 -13.08

    Forward PE

    n/a
    		 -33.21

    PS Ratio

    n/a
    		 1.97

    Forward PS

    n/a
    		 1.6

    PB Ratio

    n/a
    		 0.49

    P/FCF Ratio

    n/a
    		 -29

    PEG Ratio

    n/a
    		 0.17
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Fulgent Genetics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.85, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 4.85

    Quick Ratio

    n/a
    		 4.85

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.17

    Debt / FCF

    n/a
    		 -0.44

    Interest Coverage

    n/a
    		 -434.81

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $215,894.9

    Profits Per Employee

    n/a
    		 $-32,527.04

    Employee Count

    n/a
    		 1,313

    Asset Turnover

    n/a
    		 0.23

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -8.14M

    Effective Tax Rate

    n/a
    		 15.66%

    Stock Price Statistics

    The stock price has increased by 2.48% in the last 52 weeks. The beta is 1.07, so Fulgent Genetics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.07

    52-Week Price Change

    n/a
    		 2.48%

    50-Day Moving Average

    n/a
    		 19.65

    200-Day Moving Average

    n/a
    		 19.02

    Relative Strength Index (RSI)

    n/a
    		 47.26

    Average Volume (20 Days)

    n/a
    		 428,887

    Income Statement

    In the last 12 months, Fulgent Genetics had revenue of 283.47M and earned -42.71M in profits. Earnings per share was -1.41.

    Revenue

    n/a
    		 283.47M

    Gross Profit

    n/a
    		 107.22M

    Operating Income

    n/a
    		 -73.92M

    Net Income

    n/a
    		 -42.71M

    EBITDA

    n/a
    		 -48.99M

    EBIT

    n/a
    		 -73.92M

    Earnings Per Share (EPS)

    n/a
    		 -1.41
    Full Income Statement

    Balance Sheet

    The company has 55.14M in cash and 8.47M in debt, giving a net cash position of 46.68M.

    Cash & Cash Equivalents

    n/a
    		 55.14M

    Total Debt

    n/a
    		 8.47M

    Net Cash

    n/a
    		 46.68M

    Retained Earnings

    n/a
    		 590.47M

    Total Assets

    n/a
    		 1.21B

    Working Capital

    n/a
    		 350.87M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 21.06M and capital expenditures -40.31M, giving a free cash flow of -19.25M.

    Operating Cash Flow

    n/a
    		 21.06M

    Capital Expenditures

    n/a
    		 -40.31M

    Free Cash Flow

    n/a
    		 -19.25M

    FCF Per Share

    n/a
    		 -0.64
    Full Cash Flow Statement

    Margins

    Gross margin is 37.82%, with operating and profit margins of -26.08% and -15.07%.

    Gross Margin

    n/a
    		 37.82%

    Operating Margin

    n/a
    		 -26.08%

    Pretax Margin

    n/a
    		 -18.33%

    Profit Margin

    n/a
    		 -15.07%

    EBITDA Margin

    n/a
    		 -17.28%

    EBIT Margin

    n/a
    		 -26.08%

    FCF Margin

    n/a
    		 -6.79%

    Dividends & Yields

    FLGT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for FLGT is $24, which is 18.4% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $24

    Price Target Difference

    n/a
    		 18.4%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 5.59

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist